Capricor Therapeutics (CAPR) Net Cash Flow (QoQ) (2010 - 2026)
Capricor Therapeutics (CAPR) Net Cash Flow (QoQ) (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
| 10 |
Capricor Therapeutics |
1.53 Bn |
1.26 Bn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-167.98% |
| Dec 31, 2025 |
7,292.45% |
| Sep 30, 2025 |
32.82% |
| Jun 30, 2025 |
-131.72% |
| Mar 31, 2025 |
130.67% |
| Dec 31, 2024 |
-198.96% |
| Sep 30, 2024 |
1,189.51% |
| Jun 30, 2024 |
152.75% |
| Mar 31, 2024 |
-248.51% |
| Dec 31, 2023 |
769.84% |
| Sep 30, 2023 |
-10.94% |
| Jun 30, 2023 |
-176.66% |
| Mar 31, 2023 |
-15.75% |
| Dec 31, 2022 |
114.91% |
| Sep 30, 2022 |
80.97% |
| Jun 30, 2022 |
-278.86% |
| Mar 31, 2022 |
493.84% |
| Dec 31, 2021 |
-315.63% |
| Sep 30, 2021 |
172.63% |
| Jun 30, 2021 |
-141.26% |
